0001199719-16-000161.txt : 20161206 0001199719-16-000161.hdr.sgml : 20161206 20161206133356 ACCESSION NUMBER: 0001199719-16-000161 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161202 FILED AS OF DATE: 20161206 DATE AS OF CHANGE: 20161206 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SYNOPSYS INC CENTRAL INDEX KEY: 0000883241 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 561546236 STATE OF INCORPORATION: DE FISCAL YEAR END: 1031 BUSINESS ADDRESS: STREET 1: 690 E MIDDLEFIELD RD CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 BUSINESS PHONE: 6505845000 MAIL ADDRESS: STREET 1: 690 E MIDDLEFIELD RD CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RUNKEL JOHN F JR CENTRAL INDEX KEY: 0001206990 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19807 FILM NUMBER: 162035891 MAIL ADDRESS: STREET 1: C/O INTUITIVE SURGICAL, INC. STREET 2: 1266 KIFER ROAD CITY: SUNNYVALE STATE: CA ZIP: 94086 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2016-12-02 0 0000883241 SYNOPSYS INC SNPS 0001206990 RUNKEL JOHN F JR 690 EAST MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 0 1 0 0 General Counsel & Common Stock 2016-12-02 4 M 0 3125 39.09 A 11570 D Common Stock 2016-12-02 4 S 0 3125 56.4111 D 8445 D Common Stock 2016-12-02 4 M 0 6875 42.43 A 15320 D Common Stock 2016-12-02 4 S 0 6875 56.8346 D 8445 D Non-Qualified Stock Option (right to buy) 39.09 2016-12-02 4 M 0 3125 0.0 D 2015-05-23 2021-05-23 Common Stock 3125 16875 D Non-Qualified Stock Option (right to buy) 42.43 2016-12-02 4 M 0 6875 0.0 D 2015-03-12 2021-12-12 Common Stock 6875 42113 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $56.030 to $56.690. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range. Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $56.690 to 57.110. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range. 1/4 of the grant becomes exercisable one year after grant date with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter. Option vests in 16 equal quarterly installments beginning on the date shown. By: POA pursuant Christina Escalante-Dutra For: John Frederick Runkel, Jr. 2016-12-06